Theranostics
Showing 1 - 25 of 76
High Grade Glioma Trial (177Lu-PSMA I&T)
Not yet recruiting
- High Grade Glioma
- 177Lu-PSMA I&T
- (no location specified)
Dec 1, 2022
Imageguided Theranostics in Multiple Myeloma
Completed
- Cancer
- Myeloma
-
Sutton, Surrey, United KingdomThe Royal Marsden NHS Foundation Trust
Dec 13, 2022
Soft Tissue Sarcoma Trial (Ga-68-PSMA-11 PET/CT, Lu-177-ITG-PSMA-1)
Not yet recruiting
- Soft Tissue Sarcoma
- Ga-68-PSMA-11 PET/CT
- Lu-177-ITG-PSMA-1
- (no location specified)
Jul 7, 2022
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Melbourne (177Lu-PSMA)
Recruiting
- Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- 177Lu-PSMA
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Mar 28, 2022
Neuroendocrine Tumors Trial in New York (PET/CT Imaging, 68Ga-DOTA-JR11, 177Lu-DOTA-JR11)
Completed
- Neuroendocrine Tumors
- PET/CT Imaging
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 3, 2022
Acute Myocardial Infarction Type 1 Trial in Indianapolis (Deferiprone Tablets, Placebo)
Recruiting
- Acute Myocardial Infarction Type 1
- Deferiprone Tablets
- Placebo
-
Indianapolis, IndianaKrannert Cardiovascular Research Center
Dec 14, 2022
Breast Cancer, DCIS, Invasive Duct Carcinoma of Breast Trial in Scottsdale (LS301-IT 0.025 mg/kg, LS301-IT 0.05 mg/kg, LS301-IT
Not yet recruiting
- Breast Cancer
- +2 more
- LS301-IT 0.025 mg/kg
- +3 more
-
Scottsdale, ArizonaIntegro Theranostics Research Site #1
Jun 2, 2023
Well-Being, Psychological, Biomarkers, Cancer Trial in Coimbra (Hosting conditions, Hospital Clowns)
Completed
- Well-Being, Psychological
- +4 more
- Hosting conditions
- Hospital Clowns
-
Coimbra, Portugal
- +2 more
Nov 15, 2023
Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,
Not yet recruiting
- Carcinoid Tumor Lung
- +2 more
- 212-Lead Pentixather
- 203-Lead Pentixather SPECT/CT
-
Iowa City, IowaThe University of Iowa Theranostics Center
Sep 23, 2022
Thyroid Cancer, Medullary, Neuroendocrine Tumor of the Lung Grade 1 and 2, Neuroendocrine Tumor of the Thymus Grade 1 and 2
Recruiting
- Thyroid Cancer, Medullary
- +3 more
-
Basel, SwitzerlandUniversity Hospital Basel, Clinic for radiology and nuclear medi
May 23, 2022
Multiple Myeloma Trial in Beijing (68Ga-Pentixather, 68Ga-Pentixafor)
Recruiting
- Multiple Myeloma
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 3, 2022
Healthy Volunteers, Pancreatic Ductal Adenocarcinoma Trial (RAD301 ([68Ga]-Trivehexin))
Not yet recruiting
- Healthy Volunteers
- Pancreatic Ductal Adenocarcinoma
- RAD301 ([68Ga]-Trivehexin)
- (no location specified)
Mar 22, 2023
Solid Tumor, Lymphoma Trial in Los Angeles (DZ-002)
Recruiting
- Solid Tumor
- Lymphoma
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Mar 2, 2022
Myofascial Pain Syndrome Trial in Ávila (Sonoelastography, tensiomyography and mechanosensitivity)
Completed
- Myofascial Pain Syndrome
- Sonoelastography, tensiomyography and mechanosensitivity
-
Ávila, SpainUniversidad Católica de Ávila
Mar 16, 2023
Interstitial Lung Disease, Idiopathic Interstitial Pneumonias, Drug-Induced Pneumonitis Trial in Los Angeles (68Ga-FAPi-46,
Recruiting
- Interstitial Lung Disease
- +6 more
- 68Ga-FAPi-46
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 6, 2022
Thyroid Disease Trial in Syracuse (SPECT)
Enrolling by invitation
- Thyroid Disease
- SPECT
-
Syracuse, New YorkSUNY Upstate Medical University
Aug 31, 2023
CKD Trial in Nanjing (Fecal Microbiota Transplantation, Standard of Care for Chronic Kidney Disease)
Recruiting
- CKD
- Fecal Microbiota Transplantation
- Standard of Care for Chronic Kidney Disease
-
Nanjing, Jiangsu, Chinathe Second Affiliated of Nanjing Medical University
Apr 20, 2023
Keratoconus Trial in Catanzaro, Firenze, Messina (Riboflavin/UV-A corneal cross-linking)
Recruiting
- Keratoconus
- Riboflavin/UV-A corneal cross-linking
-
Catanzaro, Italy
- +2 more
Jul 13, 2022
Cancer Trial in Meldola, Cesena ([177Lu]Lu-PSMA I&T)
Not yet recruiting
- Cancer
- [177Lu]Lu-PSMA I&T
-
Meldola, Forlì, Italy
- +1 more
May 10, 2023
Hypoplastic Left Heart Syndrome Trial in United States (Autologous (self) mononuclear cells derived from umbilical cord blood,
Active, not recruiting
- Hypoplastic Left Heart Syndrome
- Autologous (self) mononuclear cells derived from umbilical cord blood
- Stage II Surgical repair
-
Birmingham, Alabama
- +7 more
Jan 9, 2023
Glioma, Malignant Trial in London (PET-MRI, Brain tumour biopsy)
Not yet recruiting
- Glioma, Malignant
- PET-MRI
- Brain tumour biopsy
-
London, United KingdomKing's College London
Jun 8, 2022
Plexin D1 as a Potential Biomarker inPM/DM
Not yet recruiting
- Polymyositis
- Dermatomyositis
- plexinD1
- (no location specified)
Nov 25, 2022
Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (90Y-DOTA-tyr3-Octreotide, Dosimetry-Guided Peptide
Unknown status
- Neuroendocrine Tumors
- +3 more
- 90Y-DOTA-tyr3-Octreotide
- +2 more
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Apr 25, 2019
Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,
Recruiting
- Neuroendocrine Tumors
- +4 more
- [212Pb] VMT-α-NET
- [203Pb] VMT-α-NET SPECT/CT
-
Iowa City, IowaHolden Comprehensive Cancer Center at the University of Iowa
Nov 30, 2023
Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester
Not yet recruiting
- Neuroendocrine Tumors
- +8 more
-
Iowa City, Iowa
- +1 more
Nov 23, 2022